CSIMarket
 


Amag Pharmaceuticals inc   (AMAG)
Other Ticker:  
 
 

AMAG's Net Cash Flow Growth by Quarter and Year

Amag Pharmaceuticals Inc 's Net Cash Flow results by quarter and year




AMAG Net Cash Flow (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -140.25 0.00 -65.80
III Quarter September -0.54 102.80 0.00 -2.21
II Quarter June 44.07 12.54 0.00 7.27
I Quarter March -58.55 -115.34 0.00 -21.45
FY   -15.02 -140.25 0.00 -82.19



AMAG Net Cash Flow third quarter 2020 Y/Y Growth Comment
Amag Pharmaceuticals inc in the third quarter 2020 recorded net cash outflow of $ -0.54 millions.

According to the results reported in the third quarter 2020, Amag Pharmaceuticals Inc achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Amag Pharmaceuticals Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the third quarter 2020.




AMAG Net Cash Flow ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June 251.44 % - - -84.77 %
I Quarter March - - - -
FY   - - - -

Financial Statements
Amag Pharmaceuticals Inc 's third quarter 2020 Net Cash Flow $ -0.54 millions AMAG's Income Statement
Amag Pharmaceuticals Inc 's third quarter 2019 Net Cash Flow $ 102.80 millions Quarterly AMAG's Income Statement
New: More AMAG's historic Net Cash Flow Growth >>


AMAG Net Cash Flow (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - 719.78 % - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Amag Pharmaceuticals Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AMAG's III. Quarter Q/Q Net Cash Flow Comment
III. Quarter 2020 results of -0.54 millions by Amag Pharmaceuticals inc look even worse compare to the 44.07 millions net cash outflow a quarter before.

Within Major Pharmaceutical Preparations industry Amag Pharmaceuticals inc achieved highest sequential Net Cash Flow growth. While Amag Pharmaceuticals Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AMAG's III. Quarter Q/Q Net Cash Flow Comment
Current net cash outflow of -0.54 millions by Amag Pharmaceuticals inc come out even more unfavourable if you take a look at 44.07 millions net cash outflow in the second quarter.

Within Major Pharmaceutical Preparations industry Amag Pharmaceuticals inc achieved highest sequential Net Cash Flow growth. While Amag Pharmaceuticals Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Amag Pharmaceuticals Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Net Cash Flow 12 Months Ending $ -155.27 $ -51.94 $ -83.46 $ -140.25 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
Amag Pharmaceuticals Inc ' has realized cumulative trailing twelve months net cash outflow of $ -155 millions in the Sep 30 2020 period.
The results are worsening as the cumulative net cash outflow is inflating from $ -51.94 millions for the period from Jun 30 2020 to Sep 30 2019 and $ millions for the twelve months ending in the quarter a year ago Liam  White told.

Amag Pharmaceuticals inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
Amag Pharmaceuticals Inc ' has realized cumulative trailing twelve months net cash outflow of $ -155 millions in the Sep 30 2020 period.
The business is worsening as the cumulative net cash outflow is inflating from $ -51.94 millions in TTM ending quarter Jun 30 2020 and $ millions for the twelve months ending in the quarter a year ago Liam  White told.

Amag Pharmaceuticals inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
AMAG's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for AMAG's Competitors
Net Cash Flow Growth for Amag Pharmaceuticals Inc 's Suppliers
Net Cash Flow Growth for AMAG's Customers

You may also want to know
AMAG's Annual Growth Rates AMAG's Profitability Ratios AMAG's Asset Turnover Ratio AMAG's Dividend Growth
AMAG's Roe AMAG's Valuation Ratios AMAG's Financial Strength Ratios AMAG's Dividend Payout Ratio
AMAG's Roa AMAG's Inventory Turnover Ratio AMAG's Growth Rates AMAG's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2020
Reliv International Inc-2.10%$ -2.099 millions
Nu med Plus Inc -6.63%$ -6.627 millions
Gilead Sciences Inc -8.36%$ -8.358 millions
Utah Medical Products Inc-12.65%$ -12.652 millions
Ufp Technologies Inc -16.07%$ -16.074 millions
Ptc Therapeutics inc -16.50%$ -16.495 millions
Motus Gi Holdings Inc -16.55%$ -16.546 millions
Novocure Limited-18.11%$ -18.113 millions
Irhythm Technologies Inc -26.37%$ -26.374 millions
Radnet Inc -28.23%$ -28.229 millions
Pacira Biosciences inc -35.85%$ -35.853 millions
Heartbeam Inc -36.86%$ -36.862 millions
Atreca inc -37.27%$ -37.268 millions
Crispr Therapeutics Ag-38.50%$ -38.505 millions
Progyny Inc -39.33%$ -39.326 millions
Innoviva Inc -40.25%$ -40.246 millions
Sorrento Therapeutics Inc -48.56%$ -48.559 millions
Integra Lifesciences Holdings Corp-48.95%$ -48.949 millions
Teligent Inc -53.03%$ -53.028 millions
Acadia Pharmaceuticals Inc -54.38%$ -54.376 millions
Standard Biotools Inc -57.68%$ -57.679 millions
Seelos Therapeutics inc -60.62%$ -60.623 millions
Rhythm Pharmaceuticals inc -61.25%$ -61.249 millions
Mallinckrodt Plc-62.08%$ -62.082 millions
Gw Pharmaceuticals Plc-64.51%$ -64.512 millions
Abbvie inc -65.80%$ -65.796 millions
Exicure Inc -67.68%$ -67.680 millions
Incyte Corporation-68.19%$ -68.194 millions
Frequency Therapeutics Inc -71.17%$ -71.167 millions
Homology Medicines Inc-73.31%$ -73.309 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com